Compare Centene Corp (CNC) vs Moody's Corporation (MCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Moody's Corporation — how do they compare? Centene Corp trades at $66.33 (market cap $32.89B), while Moody's Corporation trades at $476.73 (market cap $82.80B). The key difference: Moody's Corporation is far larger — about 2.5× Centene Corp's market cap, and Moody's Corporation pays a 0.86% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | MCO | |
|---|---|---|
Market Cap | $32.89B | $82.80B |
Sector | Health | Financials |
52-Week High | $68.72 | $539.61 |
52-Week Low | $26.17 | $412.23 |
Enterprise Value | $21.93B | $88.83B |
Dividend Yield | — | 0.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centene (CNC) trades at $65.77, up 2.48% with a bullish technical signal. Recent Q2 2026 earnings beat expectations with EPS of $2.51 versus $1.09 estimate, driven by margin recovery and cost control. Revenue grew to $194.78B in 2025, though net income was negative at -$6.67B. Valuation ratios are attractive with P/E of 8.06 and P/S of 0.16. Analyst consensus is strongly bullish with 61.37% buy ratings and a $70.36 price target.
Outlook is positive due to raised 2026 guidance and operational improvements, but risks include Medicaid membership softness and persistent negative margins. The stock offers value potential if profitability rebounds as projected, though investors should monitor medical cost trends and regulatory changes affecting government healthcare programs.
MCO trades at $477.75, up 0.98% on the day, with a bullish technical signal and strong fundamentals. Recent Q2 2026 earnings beat expectations with EPS of $4.68 versus $4.26 expected, driven by robust debt issuance and analytics demand. Revenue growth accelerated to 15% year-over-year, with net income margin expanding to 34.25%. The stock is supported by a consensus price target of $561.88, indicating 17.6% upside potential, and positive analyst sentiment with 56% buy ratings.
Outlook remains positive due to consistent earnings beats, high profitability, and strategic positioning in credit ratings. Risks include elevated valuation multiples, such as a P/E of 30.31, and dependence on capital market activity. Investors should weigh growth prospects against potential macroeconomic headwinds affecting debt issuance volumes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Read more on MCO →
